RavenQuest BioMed Inc. (RVVQF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 8, 2025
RavenQuest BioMed Cash Flow Statement
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | 2009 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '19 Jul 31, 2019 | Oct '18 Oct 31, 2018 | Oct '17 Oct 31, 2017 | Oct '16 Oct 31, 2016 | Oct '15 Oct 31, 2015 | Oct '14 Oct 31, 2014 | 2009 - 2013 |
| Net Income | -32.35 | -30.47 | -3.3 | -0.08 | -0.08 | -0.06 | Upgrade
|
| Depreciation & Amortization | 3.89 | 1.88 | 0 | - | 0 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 11.72 | 11.72 | 2.25 | - | - | - | Upgrade
|
| Stock-Based Compensation | 6.03 | 6.16 | 0.05 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 0.35 | 0.35 | - | - | - | - | Upgrade
|
| Other Operating Activities | 3.25 | 1.22 | 0.15 | - | - | - | Upgrade
|
| Change in Inventory | -0.74 | -0.08 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 2.04 | 0.06 | -1.42 | 0.05 | 0.06 | 0.02 | Upgrade
|
| Change in Other Net Operating Assets | 3.02 | -1.95 | -0.22 | -0 | -0 | 0 | Upgrade
|
| Operating Cash Flow | -0.93 | -11.1 | -2.5 | -0.03 | -0.02 | -0.04 | Upgrade
|
| Capital Expenditures | -7.17 | -12.26 | -0 | - | - | - | Upgrade
|
| Cash Acquisitions | -0.63 | -16.28 | -0.16 | - | - | - | Upgrade
|
| Other Investing Activities | - | - | - | - | - | 0.03 | Upgrade
|
| Investing Cash Flow | -7.8 | -28.54 | -0.16 | - | - | 0.03 | Upgrade
|
| Short-Term Debt Issued | - | - | 0.04 | 0.03 | 0.01 | 0.01 | Upgrade
|
| Long-Term Debt Issued | - | 14.01 | - | - | - | - | Upgrade
|
| Total Debt Issued | 0.61 | 14.01 | 0.04 | 0.03 | 0.01 | 0.01 | Upgrade
|
| Short-Term Debt Repaid | - | -0.2 | -0.12 | - | - | - | Upgrade
|
| Total Debt Repaid | -0.4 | -0.2 | -0.12 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 0.21 | 13.81 | -0.08 | 0.03 | 0.01 | 0.01 | Upgrade
|
| Issuance of Common Stock | 9.76 | 24.44 | 6.58 | - | - | - | Upgrade
|
| Other Financing Activities | -1.84 | -1.62 | -0.46 | - | - | - | Upgrade
|
| Financing Cash Flow | 8.13 | 36.63 | 6.03 | 0.03 | 0.01 | 0.01 | Upgrade
|
| Net Cash Flow | -0.61 | -3.02 | 3.38 | -0 | -0.01 | 0.01 | Upgrade
|
| Free Cash Flow | -8.11 | -23.36 | -2.5 | -0.03 | -0.02 | -0.04 | Upgrade
|
| Free Cash Flow Margin | -532.79% | -1858.93% | -2222.11% | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.26 | -0.08 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Cash Interest Paid | 1.61 | 0.55 | 0.01 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -3.3 | -13.84 | -0.18 | 0 | 0.01 | 0.01 | Upgrade
|
| Unlevered Free Cash Flow | -1.31 | -12.65 | -0.09 | 0 | 0.01 | 0.01 | Upgrade
|
| Change in Net Working Capital | -4.56 | 0.53 | -0.24 | -0.05 | -0.06 | -0.06 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.